Manuela Schmidinger
Papers
2
Total Citations
2,773
H-Index
2
About
Manuela Schmidinger is a leading authority in the clinical management of renal cell carcinoma (RCC), with her work fundamentally shaping how this disease is diagnosed, treated, and monitored. As a key contributor to the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines, she has helped establish the global standard of care for RCC. Her most cited work, the 2014 ESMO guidelines, has accumulated over 2,250 citations, underscoring its profound impact on clinical decision-making and research directions. A subsequent 2016 update, with over 500 citations, reflects the rapid evolution of treatment paradigms she has helped drive. Beyond guideline authorship, Schmidinger is recognized for her expertise in targeted therapies and immunotherapy sequencing in advanced kidney cancer. Her contributions have been instrumental in translating complex clinical trial data into practical, life-saving treatment algorithms. For students and researchers, her work represents a masterclass in evidence-based oncology, demonstrating how rigorous guideline development can directly improve patient outcomes in a challenging malignancy.
Research Focus
Key Achievements
Top Papers
- 1
- 2